Literature DB >> 15866875

Characterization of the final step in the conversion of phytol into phytanic acid.

Daan M van den Brink1, Joram N I van Miert, Georges Dacremont, Jean-François Rontani, Ronald J A Wanders.   

Abstract

Phytol is a branched-chain fatty alcohol that is a naturally occurring precursor of phytanic acid, a fatty acid involved in the pathogenesis of Refsum disease. The conversion of phytol into phytanic acid is generally believed to take place via three enzymatic steps that involve 1) oxidation to its aldehyde, 2) further oxidation to phytenic acid, and 3) reduction of the double bond at the 2,3 position, yielding phytanic acid. Our recent investigations of this mechanism have elucidated the enzymatic steps leading to phytenic acid production, but the final step of the pathway has not been investigated so far. In this study, we describe the characterization of phytenic acid reduction in rat liver. NADPH-dependent conversion of phytenic acid into phytanic acid was detected, although at a slow rate. However, it was shown that phytenic acid can be activated to its CoA ester and that reduction of phytenoyl-CoA is much more efficient than that of phytenic acid. Furthermore, in rat hepatocytes cultured in the presence of phytol, phytenoyl-CoA could be detected, showing that it is a bona fide intermediate of phytol degradation. Subcellular fractionation experiments revealed that phytenoyl-CoA reductase activity is present in peroxisomes and mitochondria. With these findings, we have accomplished the full elucidation of the mechanism by which phytol is converted into phytanic acid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866875     DOI: 10.1074/jbc.M501861200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The tail of chlorophyll: fates for phytol.

Authors:  Timothy P Durrett; Ruth Welti
Journal:  J Biol Chem       Date:  2021-05-19       Impact factor: 5.157

2.  The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.

Authors:  Aigar Ottas; Dmytro Fishman; Tiia-Linda Okas; Külli Kingo; Ursel Soomets
Journal:  Arch Dermatol Res       Date:  2017-07-10       Impact factor: 3.017

Review 3.  Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.

Authors:  Gerd Bobe; Zhenzhen Zhang; Ryan Kopp; Mark Garzotto; Jackilen Shannon; Yumie Takata
Journal:  Eur J Cancer Prev       Date:  2020-03       Impact factor: 2.164

Review 4.  Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations.

Authors:  Chuck T Chen; Zhuo Shao; Zhongjie Fu
Journal:  Front Cell Dev Biol       Date:  2022-09-07

5.  Phytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations.

Authors:  Mohamed M Elmazar; Hanan S El-Abhar; Mona F Schaalan; Nahla A Farag
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

6.  Peroxisome biogenesis disorders.

Authors:  Catherine Argyriou; Maria Daniela D'Agostino; Nancy Braverman
Journal:  Transl Sci Rare Dis       Date:  2016-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.